Literature DB >> 22273037

Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method.

Karel Allegaert1, Maike Kuppens, Djalila Mekahli, Elena Levtchenko, Florent Vanstapel, Christine Vanhole, John N van den Anker.   

Abstract

OBJECTIVE: Serum creatinine (Scr) reflects to a certain extent glomerular filtration rate in neonates, but postnatal observations also depends on the technique used to quantify Scr (Jaffe colorimetry or enzymatic quantification).
METHODS: In an attempt to quantify differences between these techniques, we compared postnatal Scr trends in two consecutive cohorts of extremely low birth-weight (ELBW) neonates before and following a switch from uncompensated Jaffe to enzymatic Scr quantification. Postnatal Scr (Days 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 21, 28, and 42) in 151 ELBW neonates (uncompensated Jaffe) was compared to 116 more recently admitted ELBW neonates (enzymatic).
RESULTS: Although clinical characteristics were similar between both cohorts, median postnatal Jaffe Scr values were significantly higher compared to enzymatic quantification (all days, at least p < 0.001) throughout postnatal life. While both cohorts displayed a similar trend with an initial increase with a Scr peak on Days 3 and 4 and a subsequent decrease, the difference in within-day median values fluctuated between 11 and 24 mmol.L(-1). There is neither fixed nor relative difference in Scr between both techniques.
CONCLUSIONS: When using Scr to estimate renal function in ELBW neonates, clinicians should in addition to the postnatal changes and other covariates of renal function, also consider the technique applied. We provide reference values and comparison between both techniques.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22273037     DOI: 10.3109/14767058.2012.657277

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  15 in total

1.  Renal Clearance in Newborns and Infants: Predictive Performance of Population-Based Modeling for Drug Development.

Authors:  Jian Wang; Shaun S Kumar; Catherine M Sherwin; Robert Ward; Gerri Baer; Gilbert J Burckart; Yaning Wang; Lynne P Yao
Journal:  Clin Pharmacol Ther       Date:  2019-02-10       Impact factor: 6.875

Review 2.  Cystatin C in newborns: a promising renal biomarker in search for standardization and validation.

Authors:  Karel Allegaert; Djalila Mekahli; John van den Anker
Journal:  J Matern Fetal Neonatal Med       Date:  2014-11-05

3.  Caffeine exposure and acute kidney injury in premature infants with necrotizing enterocolitis and spontaneous intestinal perforation.

Authors:  Noelia Aviles-Otero; Reeti Kumar; Dev Darshan Khalsa; Glen Green; J Bryan Carmody
Journal:  Pediatr Nephrol       Date:  2018-11-10       Impact factor: 3.714

4.  Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?

Authors:  A Kontou; K Sarafidis; O Begou; H G Gika; A Tsiligiannis; K Ogungbenro; A Dokoumetzidis; E Agakidou; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

5.  External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.

Authors:  Wei Zhao; Florentia Kaguelidou; Valérie Biran; Daolun Zhang; Karel Allegaert; Edmund V Capparelli; Nick Holford; Toshimi Kimura; Yoke-Lin Lo; José-Esteban Peris; Alison Thomson; John N van den Anker; May Fakhoury; Evelyne Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

6.  Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.

Authors:  Roosmarijn F W De Cock; Karel Allegaert; Janneke M Brussee; Catherine M T Sherwin; Hussain Mulla; Matthijs de Hoog; Johannes N van den Anker; Meindert Danhof; Catherijne A J Knibbe
Journal:  Pharm Res       Date:  2014-05-02       Impact factor: 4.200

7.  Association between vancomycin trough concentration and area under the concentration-time curve in neonates.

Authors:  Adam Frymoyer; Adam L Hersh; Mohammed H El-Komy; Shabnam Gaskari; Felice Su; David R Drover; Krisa Van Meurs
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

8.  High-dose gentamicin in newborn infants: is it safe?

Authors:  Jon Widding Fjalstad; Einar Laukli; John N van den Anker; Claus Klingenberg
Journal:  Eur J Pediatr       Date:  2013-11-14       Impact factor: 3.183

9.  Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.

Authors:  Jiraganya Bhongsatiern; Chris Stockmann; Jessica K Roberts; Tian Yu; Kent E Korgenski; Michael G Spigarelli; Pankaj B Desai; Catherine M T Sherwin
Journal:  Ther Drug Monit       Date:  2015-12       Impact factor: 3.681

10.  Recognition and reporting of AKI in very low birth weight infants.

Authors:  J Bryan Carmody; Jonathan R Swanson; Erika T Rhone; Jennifer R Charlton
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.